Financial Snapshot

Revenue
$45.67M
TTM
Gross Margin
32.33%
TTM
Net Earnings
-$9.606M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
197.58%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$32.44M
Q3 2024
Cash
Q3 2024
P/E
-12.49
Nov 29, 2024 EST
Free Cash Flow
$3.153M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Revenue $65.49M $47.64M $38.35M $62.90M $54.69M $34.24M $19.24M $9.199M $4.364M $3.523M $0.00 $34.87M $8.386M $6.642M $390.0K $0.00 $0.00 $0.00 $150.0K $430.0K $0.00 $0.00 $0.00 $0.00 $3.560M $8.040M $0.00 $0.00
YoY Change 37.48% 24.22% -39.03% 15.0% 59.73% 77.94% 109.17% 110.79% 23.87% -100.0% 315.81% 26.26% 1603.08% -100.0% -65.12% -100.0% -55.72%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Revenue $65.49M $47.64M $38.35M $62.90M $54.69M $34.24M $19.24M $9.199M $4.364M $3.523M $0.00 $34.87M $8.386M $6.642M $390.0K $0.00 $0.00 $0.00 $150.0K $430.0K $0.00 $0.00 $0.00 $0.00 $3.560M $8.040M $0.00 $0.00
Cost Of Revenue $22.98M $19.59M $16.35M $10.87M $10.90M $9.302M $15.23M $8.398M $730.0K $630.0K $0.00 $8.144M $1.525M $4.383M $3.580M $0.00 $0.00 $0.00 $40.00K $120.0K $0.00 $1.280M $2.860M $0.00
Gross Profit $42.51M $28.05M $22.00M $52.03M $43.80M $24.94M $4.011M $801.0K $3.634M $2.893M $0.00 $26.28M $1.443M $6.861M -$3.190M $0.00 $0.00 $0.00 $120.0K $310.0K $0.00 $2.270M $5.180M $0.00
Gross Profit Margin 64.91% 58.87% 57.37% 82.71% 80.08% 72.83% 20.85% 8.71% 83.27% 82.12% 75.37% 17.21% 103.3% -817.95% 80.0% 72.09% 63.76% 64.43%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Selling, General & Admin $14.96M $11.71M $12.73M $11.15M $9.899M $10.92M $11.53M $9.356M $7.279M $9.228M $8.051M $9.763M $6.930M $6.880M $6.950M $6.640M $20.59M $4.450M $2.070M $810.0K $140.0K $170.0K $290.0K $380.0K $2.030M $3.140M $630.0K $40.00K
YoY Change 27.73% -8.0% 14.18% 12.62% -9.32% -5.33% 23.24% 28.53% -21.12% 14.62% -17.54% 40.88% 0.73% -1.01% 4.67% -67.75% 362.7% 114.98% 155.56% 478.57% -17.65% -41.38% -23.68% -81.28% -35.35% 398.41% 1475.0%
% of Gross Profit 35.19% 41.76% 57.86% 21.43% 22.6% 43.77% 287.46% 1168.04% 200.3% 318.98% 37.15% 480.25% 100.28% 1725.0% 261.29% 89.43% 60.62%
Research & Development $17.09M $29.35M $29.73M $38.17M $44.62M $33.33M $32.17M $30.41M $24.89M $27.35M $29.23M $36.67M $37.82M $37.69M
YoY Change -41.76% -1.29% -22.1% -14.45% 33.86% 3.61% 5.78% 22.19% -9.0% -6.41% -20.29% -3.05% 0.34%
% of Gross Profit 40.21% 104.65% 135.15% 73.36% 101.87% 133.65% 802.04% 3796.75% 684.89% 945.45% 139.52% 2620.79% 549.35%
Depreciation & Amortization $1.200M $1.100M $1.100M $1.300M $1.600M $1.700M $1.920M $1.983M $2.370M $3.140M $3.539M $3.692M $3.630M $3.130M $1.990M $1.300M $760.0K $500.0K $310.0K $120.0K $0.00 $0.00 $0.00 $0.00 $160.0K $200.0K $0.00 $0.00
YoY Change 9.09% 0.0% -15.38% -18.75% -5.88% -11.46% -3.18% -16.33% -24.52% -11.27% -4.14% 1.71% 15.97% 57.29% 53.08% 71.05% 52.0% 61.29% 158.33% -100.0% -20.0%
% of Gross Profit 2.82% 3.92% 5.0% 2.5% 3.65% 6.82% 47.87% 247.57% 65.22% 108.54% 14.05% 251.56% 45.62% 258.33% 38.71% 7.05% 3.86%
Operating Expenses $32.05M $41.06M $42.46M $49.32M $54.52M $44.25M $43.70M $39.77M $32.17M $36.58M $37.28M $46.43M $37.82M $37.69M $28.78M $24.17M $34.16M $9.770M $5.900M $2.730M $150.0K $170.0K $300.0K $380.0K $3.100M $5.550M $630.0K $40.00K
YoY Change -21.94% -3.3% -13.89% -9.54% 23.21% 1.25% 9.89% 23.63% -12.06% -1.87% -19.71% 22.77% 0.34% 30.96% 19.07% -29.24% 249.64% 65.59% 116.12% 1720.0% -11.76% -43.33% -21.05% -87.74% -44.14% 780.95% 1475.0%
Operating Profit $10.46M -$13.01M -$20.46M $2.710M -$10.72M -$19.31M -$34.52M -$33.16M -$23.67M -$28.56M -$34.06M -$12.17M -$36.53M -$29.97M -$31.97M -$24.17M -$34.16M -$9.770M -$5.780M -$2.420M -$380.0K -$830.0K -$370.0K -$630.0K
YoY Change -180.37% -36.4% -855.06% -125.29% -44.49% -44.06% 4.08% 40.11% -17.12% -16.16% 179.85% -66.68% 21.91% -6.27% 32.27% -29.24% 249.64% 69.03% 138.84% -54.22% 124.32% -41.27%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Interest Expense -$1.515M -$1.310M -$5.030M -$7.380M -$7.560M -$7.150M -$47.60M -$10.08M $3.549M $3.549M $1.015M $550.0K $0.00 $970.0K $530.0K $1.760M $2.080M $340.0K $40.00K $0.00 $10.00K $20.00K $60.00K $130.0K $70.00K $30.00K -$10.00K $240.0K
YoY Change 15.65% -73.96% -31.84% -2.38% 5.73% -84.98% 372.22% -384.02% 0.0% 249.66% 84.55% -100.0% 83.02% -69.89% -15.38% 511.76% 750.0% -100.0% -50.0% -66.67% -53.85% 85.71% 133.33% -400.0% -104.17%
% of Operating Profit -14.48% -272.32%
Other Income/Expense, Net -$1.894M -$1.383M -$7.120M -$9.233M -$7.559M -$7.149M -$48.92M $3.987M -$3.612M -$4.739M -$674.0K $554.0K $2.000K $0.00 $0.00 $0.00 $0.00 $0.00 $120.0K $0.00
YoY Change 36.95% -80.58% -22.89% 22.15% 5.74% -85.39% -1327.06% -210.38% -23.78% 603.12% -221.66% 27600.0% -100.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Pretax Income $8.566M -$14.40M -$27.58M -$6.523M -$18.28M -$26.46M -$83.44M -$29.18M -$27.28M -$33.30M -$34.74M -$11.62M -$36.53M -$36.74M -$31.44M -$22.41M -$32.08M -$9.430M -$5.750M -$2.420M -$140.0K -$150.0K -$330.0K -$110.0K -$1.000M -$1.150M -$630.0K $200.0K
YoY Change -159.5% -47.8% 322.84% -64.32% -30.91% -68.29% 185.95% 6.96% -18.08% -4.15% 198.97% -68.19% -0.57% 16.86% 40.29% -30.14% 240.19% 64.0% 137.6% 1628.57% -6.67% -54.55% 200.0% -89.0% -13.04% 82.54% -415.0%
Income Tax $254.0K $530.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $70.00K
% Of Pretax Income 2.97% 35.0%
Net Earnings $8.312M -$14.93M -$27.58M -$6.523M -$18.28M -$26.46M -$83.44M -$29.37M $58.04M -$29.94M -$27.79M -$11.62M -$36.53M -$29.00M -$31.44M -$22.41M -$32.08M -$9.390M -$5.750M -$2.420M -$140.0K -$150.0K -$330.0K -$110.0K -$1.000M -$1.150M -$630.0K $130.0K
YoY Change -155.68% -45.88% 322.84% -64.31% -30.92% -68.29% 184.15% -150.6% -293.82% 7.75% 139.2% -68.2% 25.97% -7.77% 40.29% -30.14% 241.64% 63.3% 137.6% 1628.57% -6.67% -54.55% 200.0% -89.0% -13.04% 82.54% -584.62%
Net Earnings / Revenue 12.69% -31.33% -71.92% -10.37% -33.42% -77.27% -433.63% -319.22% 1329.9% -849.93% -33.32% -435.6% -436.59% -8061.54% -3833.33% -562.79% -28.09% -14.3%
Basic Earnings Per Share $0.12 -$0.31 -$0.62 -$0.22 -$1.23
Diluted Earnings Per Share $0.09 -$0.31 -$0.62 -$0.22 -$1.23 -$1.80 -$6.37 -$2.88 $6.11 -$3.22 -$3.00 -$1.28 -$4.32 -$4.54 -$4.09 -$2.95 -$4.78 -$3.22 -$3.06 -$1.29 -$4.66 -$5.00 -$11.00 -$2.75 -$20.00 -$22.99 -$63.00 $6.50

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Cash & Short-Term Investments $23.63M $17.10M $39.00M $18.30M $17.80M $38.00M $51.40M $64.30M $77.00M $56.00M $86.80M $54.40M $28.30M $35.90M $81.30M $42.60M $61.80M $15.40M $4.700M $600.0K $700.0K $800.0K $900.0K $1.600M $1.500M $1.300M $100.0K $800.0K
YoY Change 38.21% -56.15% 113.11% 2.81% -53.16% -26.07% -20.06% -16.49% 37.5% -35.48% 59.56% 92.23% -21.17% -55.84% 90.85% -31.07% 301.3% 227.66% 683.33% -14.29% -12.5% -11.11% -43.75% 6.67% 15.38% 1200.0% -87.5%
Cash & Equivalents $23.63M $17.10M $39.00M $18.30M $17.80M $37.80M $51.20M $63.30M $76.40M $54.80M $86.40M $52.00M $27.00M $35.90M $81.30M $42.60M $61.80M $15.40M $4.700M $600.0K $200.0K $800.0K $900.0K $400.0K $400.0K $1.300M $100.0K $800.0K
Short-Term Investments $0.00 $200.0K $200.0K $1.000M $600.0K $1.200M $400.0K $2.400M $1.300M $600.0K $0.00 $0.00 $1.200M $1.100M
Other Short-Term Assets $21.98M $6.400M $1.300M $22.30M $1.800M $1.700M $1.700M $1.600M $3.100M $6.100M $1.100M $1.300M $2.500M $600.0K $400.0K $400.0K $300.0K $7.600M $0.00 $0.00 $0.00 $0.00 $0.00 $200.0K $200.0K $200.0K $0.00 $6.600M
YoY Change 243.45% 392.31% -94.17% 1138.89% 5.88% 0.0% 6.25% -48.39% -49.18% 454.55% -15.38% -48.0% 316.67% 50.0% 0.0% 33.33% -96.05% -100.0% 0.0% 0.0% -100.0%
Inventory $19.05M $16.80M $18.00M $13.10M $8.200M $8.600M $7.800M $5.200M $5.800M $3.500M $8.000M $4.000M $300.0K $1.200M $0.00
Prepaid Expenses
Receivables $5.272M $4.600M $3.400M $2.000M $4.700M $4.700M $1.700M $700.0K $2.100M $1.400M $1.400M $7.000M $300.0K $0.00 $1.100M $0.00
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.700M $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $69.93M $44.90M $61.70M $55.70M $32.50M $53.00M $62.70M $71.90M $85.90M $65.50M $97.90M $61.20M $32.50M $46.30M $83.40M $43.40M $63.20M $24.30M $5.000M $600.0K $700.0K $800.0K $1.000M $1.800M $1.600M $2.600M $100.0K $7.300M
YoY Change 55.75% -27.23% 10.77% 71.38% -38.68% -15.47% -12.8% -16.3% 31.15% -33.09% 59.97% 88.31% -29.81% -44.48% 92.17% -31.33% 160.08% 386.0% 733.33% -14.29% -12.5% -20.0% -44.44% 12.5% -38.46% 2500.0% -98.63%
Property, Plant & Equipment $10.88M $9.600M $9.900M $10.40M $11.00M $6.400M $7.700M $8.700M $9.700M $11.30M $13.70M $16.30M $18.30M $17.50M $14.50M $6.800M $4.500M $2.400M $2.000M $0.00 $800.0K $0.00
YoY Change 13.35% -3.03% -4.81% -5.45% 71.88% -16.88% -11.49% -10.31% -14.16% -17.52% -15.95% -10.93% 4.57% 20.69% 113.24% 51.11% 87.5% 20.0% -100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.620M $1.300M $2.100M $1.800M $2.000M $1.800M $1.900M $1.700M $1.600M $1.600M $1.700M $1.200M $1.000M $900.0K $700.0K $600.0K $500.0K $300.0K $200.0K $0.00 $100.0K $200.0K $1.000M $0.00 $0.00
YoY Change 178.46% -38.1% 16.67% -10.0% 11.11% -5.26% 11.76% 6.25% 0.0% -5.88% 41.67% 20.0% 11.11% 28.57% 16.67% 20.0% 66.67% 50.0% -100.0% -50.0% -80.0%
Total Long-Term Assets $14.50M $10.90M $12.00M $12.20M $12.90M $8.100M $9.500M $10.30M $11.40M $12.90M $15.40M $17.50M $19.30M $18.40M $15.30M $7.400M $4.900M $2.700M $2.200M $0.00 $0.00 $100.0K $0.00 $100.0K $400.0K $2.200M $0.00 $0.00
YoY Change 33.05% -9.17% -1.64% -5.43% 59.26% -14.74% -7.77% -9.65% -11.63% -16.23% -12.0% -9.33% 4.89% 20.26% 106.76% 51.02% 81.48% 22.73% -100.0% -100.0% -75.0% -81.82%
Total Assets $84.43M $55.80M $73.70M $67.90M $45.40M $61.10M $72.20M $82.20M $97.30M $78.40M $113.3M $78.70M $51.80M $64.70M $98.70M $50.80M $68.10M $27.00M $7.200M $600.0K $700.0K $900.0K $1.000M $1.900M $2.000M $4.800M $100.0K $7.300M
YoY Change
Accounts Payable $4.320M $5.900M $7.000M $7.200M $6.500M $5.200M $7.500M $4.000M $3.600M $3.800M $11.20M $9.600M $7.800M $6.300M $3.400M $2.200M $900.0K $900.0K $400.0K $0.00 $0.00 $0.00 $100.0K $500.0K $300.0K $1.200M $100.0K
YoY Change -26.78% -15.71% -2.78% 10.77% 25.0% -30.67% 87.5% 11.11% -5.26% -66.07% 16.67% 23.08% 23.81% 85.29% 54.55% 144.44% 0.0% 125.0% -100.0% -80.0% 66.67% -75.0% 1100.0%
Accrued Expenses $12.37M $11.10M $15.50M $13.00M $10.40M $8.000M $6.800M $5.300M $3.600M $5.300M $4.200M $3.800M $3.400M $3.200M $4.700M $1.700M $1.800M $1.100M $100.0K $100.0K $100.0K $0.00
YoY Change 11.41% -28.39% 19.23% 25.0% 30.0% 17.65% 28.3% 47.22% -32.08% 26.19% 10.53% 11.76% 6.25% -31.91% 176.47% -5.56% 63.64% 0.0% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $4.100M $4.300M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $500.0K $0.00
YoY Change -100.0% -4.65% -100.0%
Long-Term Debt Due $20.25M $54.40M $5.900M $53.90M $0.00 $100.0K $0.00 $0.00
YoY Change -89.05% -100.0%
Total Short-Term Liabilities $45.53M $32.40M $33.20M $86.50M $40.20M $25.40M $22.80M $66.20M $11.20M $64.40M $26.70M $25.80M $18.70M $18.90M $21.50M $5.500M $3.800M $2.300M $800.0K $100.0K $100.0K $100.0K $100.0K $600.0K $500.0K $1.400M $600.0K $100.0K
YoY Change 40.52% -2.41% -61.62% 115.17% 58.27% 11.4% -65.56% 491.07% -82.61% 141.2% 3.49% 37.97% -1.06% -12.09% 290.91% 44.74% 65.22% 187.5% 700.0% 0.0% 0.0% 0.0% -83.33% 20.0% -64.29% 133.33% 500.0%
Long-Term Debt $0.00 $28.20M $27.90M $100.0K $51.50M $53.30M $51.30M $23.60M $72.10M $67.40M $67.00M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -100.0% 1.08% 27800.0% -99.81% -3.38% 3.9% 117.37% -67.27% 6.97% 0.6%
Other Long-Term Liabilities $5.335M $5.800M $18.60M $8.400M $24.10M $35.40M $27.60M $2.300M $3.000M $2.300M $46.50M $56.30M $59.20M $57.10M $61.30M $900.0K $700.0K $400.0K $300.0K $0.00 $300.0K $7.300M
YoY Change -8.02% -68.82% 121.43% -65.15% -31.92% 28.26% 1100.0% -23.33% 30.43% -95.05% -17.41% -4.9% 3.68% -6.85% 6711.11% 28.57% 75.0% 33.33% -100.0% -95.89%
Total Long-Term Liabilities $5.335M $34.00M $46.50M $8.500M $75.60M $88.70M $78.90M $25.90M $75.10M $69.70M $113.5M $56.30M $59.20M $57.10M $61.30M $900.0K $700.0K $400.0K $300.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $300.0K $7.300M
YoY Change -84.31% -26.88% 447.06% -88.76% -14.77% 12.42% 204.63% -65.51% 7.75% -38.59% 101.6% -4.9% 3.68% -6.85% 6711.11% 28.57% 75.0% 33.33% -100.0% -95.89%
Total Liabilities $50.87M $66.40M $79.70M $95.00M $115.7M $114.0M $101.7M $92.20M $86.40M $134.0M $140.3M $82.10M $77.90M $76.10M $82.80M $6.500M $4.500M $2.700M $1.100M $100.0K $100.0K $100.0K $100.0K $600.0K $500.0K $1.400M $900.0K $7.300M
YoY Change -23.4% -16.69% -16.11% -17.89% 1.49% 12.09% 10.3% 6.71% -35.52% -4.49% 70.89% 5.39% 2.37% -8.09% 1173.85% 44.44% 66.67% 145.45% 1000.0% 0.0% 0.0% 0.0% -83.33% 20.0% -64.29% 55.56% -87.67%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Basic Shares Outstanding 67.51M 48.47M 44.14M 29.15M 14.84M
Diluted Shares Outstanding 82.42M 48.47M 44.14M 29.15M 14.84M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $120.02 Million

About Protalix BioTherapeutics, Inc.

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. The company is headquartered in Hackensack, New Jersey and currently employs 208 full-time employees. The company went IPO on 2010-09-06. The firm is focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ProCellEx. In addition, the Company is developing PEGylated uricase, or PRX-115, for the treatment of severe gout, Long Acting (LA) DNase I, or PRX-119, for the treatment of NETs-related diseases, and other technologies and preclinical assets. Its product, Elelyso is an enzyme replacement therapy (ERT) for the treatment of patients with Gaucher disease. Its ProCellEx platform is being used to manufacture both of its approved and marketed products as well as PRX-115 and PRX-119. PRX-115, a plant cell-expressed recombinant PEGylated Uricase (urate oxidase)- a chemically modified enzyme under development for the potential treatment of severe gout. PRX-119 is a plant cell-expressed PEGylated recombinant human DNase I product candidate.

Industry: Biological Products, (No Diagnostic Substances) Peers: Enlivex Therapeutics Ltd. CollPlant Biotechnologies Ltd Entera Bio Ltd. Evogene Ltd. Gamida Cell Ltd.